CTRI/2018/02/011992已完成未知
A randomized open label study to Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Any patient with only acute esophageal variceal bleeding (as defined by Asian pacific Association for the study of Liver Disease)
- •2) Informed consent to participate in the study
- •3) Age 18 to 70 years
排除标准
- •1) Pregnant and lactation
- •2) Prior treatment with any vasoactive drugs
- •3) Significant heart or respiratory failure
- •4) Peripheral arteriopathy clinically significant
- •5) Previous heart stroke or significant alteration of the Electrocardiogram
- •6) Hemodynamically unstable
- •7) Refusal to participate in the study
- •8) Hypertension
研究者
相似试验
已完成
不适用
A randomised, open label, controlled trial to assess the efficacy and safety of dihydroartemisinin-piperaquine for the treatment of primary and the prevention of secondary infections with Plasmodium falciparumncomplicated Plasmodium falciparum malariaInfections and InfestationsPlasmodium falciparum malariaISRCTN88705995niversity of Heidelberg School of Medicine (Germany)500
已完成
3 期
A Randomized Open-Label Study on Safety and Efficacy of Chondrotissue® in Microfracture Treatment of Local Femoral Cartilage Defects in the Knee - chondrotissue® in microfracture treatmentfull-thickness traumatic or degenerative cartilage defects on femorale condyles of the knee jointM17M94.86Gonarthrosis [arthrosis of knee]DRKS00016701BioTissue AG30
进行中（未招募）
不适用
Comparison of safety and efficacy of vildagliptin versus NPH insulin add-on to glimepiride in patients with type 2 diabetes mellitusEUCTR2012-001143-46-DEovartis Pharma GmbH
进行中（未招募）
不适用
A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naive HIV-1/HCV Co-infected SubjectsTreatment of HIV infection in Antiretroviral-Naive HIV-1/HCV Co-infected Subjects.MedDRA version: 6.1Level: PTClassification code 10020161EUCTR2005-001431-30-ITABBOTT
进行中（未招募）
不适用
A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naïve HIV-1/HCV Co-infected SubjectsHIV-1 infectionEUCTR2005-001431-30-IEAbbott GmbH & Co. KG200